Emeis shares fall below their €9.75 support and drop 33% over three months

A support giving way after the third-quarter figures

Emeis fell 2.21% to €9.75 during the session, while the CAC 40 gained 0.48%. The stock broke its €9.75 support and remains below it. It is nearly 14% below its 50-day moving average (MM50) and more than 27% below its 200-day moving average (MM200), illustrating the scale of the slide: the stock has shed 33% over three months. This session extends an already long-standing decline, despite fairly solid activity figures published on October 29.

For the first nine months, revenue reached €4,543 million, up 6% organically, with an occupancy rate of 90.2%. The group stated that these trends support its 2026 targets, which were raised at the end of July. This release therefore did not prevent the stock from falling.

One of the weakest stocks in the SBF 120 in a buoyant market

Within the SBF 120, which rose 0.42% at midday, Emeis is among the index's biggest decliners. The stock trades well below its medium-term benchmarks: the MM20 stands at €10.03, nearly 3% above the share price, and the RSI is at 35.

The group, which operates medicalised nursing homes, psychiatric clinics and senior residences in Europe, had already seen its share price fall back below €10 several times since October 22.

Among the risks cited when the nine-month 2026 results were published on October 29, 2026, was dependence on the continuation of operational efficiency programmes, such as the Boost initiative in France.